Webinar: CHOp your protein production timelines

About the Webinar

Register to learn how to drive your biologics development forward by leveraging MaxCyte’s flow electroporation technology. This flexible, scalable technology enables alternative strategies for the rapid development of high-yielding stable cell lines and can deliver gram-scale transient protein production within two weeks.

Learning Objectives:

  • Understand how MaxCyte’s high-performance electroporation technology can be utilized for both transient and stable protein production applications, and learn the benefits of a parallel approach
  • Hear guidance on how to optimize and scale with MaxCyte to reduce costs and shrink timelines
  • Compare workflows and productivity of transient gene expression, bulk pools and mini-pools


James Brady Maxcyte

James Brady, PhD

Senior Vice President, Technical Applications and Customer Support
MaxCyte, Inc.

Dr. Brady is an experienced biotechnology industry professional with expertise in gene and cellular therapy, biologics, and drug discovery. Previously, he was a Senior Scientist at Genetic Therapy, a Novartis subsidiary, where he worked on lentiviral-based gene therapy treatments and a Group Leader at MetaMorphix, managing the company’s transgenic and genetic research programs.

Dr. Brady earned a Master of Business Administration in finance from The Johns Hopkins University. He completed his postdoctoral fellow at the National Eye Institute of the National Institutes of Health in Bethesda, Maryland after obtaining a PhD in genetics from Indiana University in Bloomington, and a Bachelor of Science in biology from the College of William and Mary in Virginia.


Caroline Romanelli

Sales Manager, Mid-Atlantic and South East
MaxCyte, Inc.

After earning her MS. Biochemistry from the University of Delaware, Caroline spent 10 years at Bristol-Myers Squibb in Leads Discovery and Optimization, focusing on label-free assay development, lab automation, and fragment screening. Since leaving the bench, Caroline has enjoyed providing innovative solutions in today’s fast-paced life science industry, when not with her daughters, at the beach, or watching Philadelphia sports.


Megan Embrey

Senior Field Application Scientist, Mid-Atlantic
MaxCyte, Inc.

Megan is based in Bethesda Maryland, working alongside MaxCyte’s portfolio of protein production and cell therapy clients. Professionally, Megan has worked as a cell biologist at the University of Virginia and earned an MS. in microbiology from the University of Maine. Outside of work, Megan helps lead a Women in Biology - Peer Mentorship program, enjoys hiking, and is always looking for a new recipe to try.

Access On Demand Webinar

Please fill form below to continue to the webinar

Leave a Comment